FGEN | FibroGen, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.3466 - 0.4250
52 Week Range	0.1800 - 2.9300
Beta	0.48
Implied Volatility	476.63%
IV Rank	84.59%
Day's Volume	3,351,963
Average Volume	1,172,385
Shares Outstanding	100,770,000
Market Cap	40,308,000
Sector	Healthcare
Industry	Biotechnology
IPO Date	2014-11-14

Valuation
Profitability
Growth
Health
P/E Ratio	-0.33
Forward P/E Ratio	N/A
EPS	-1.23
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	486
Country	USA
Website	FGEN

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

FGEN's peers: ARDX, ZURA, HEPA, AVRO, VSTM, MREO, BPMC, AGIO, DAWN, BMRN, LYEL, CGEM, GLUE, THRX, RVMD, BMEA, STOK, AKRO, FIXX, GOSS, PCVX, LRMR, SNDX, MRUS, STRO

*Chart delayed

Analyzing fundamentals for FGEN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see FGEN Fundamentals page.

Watching at FGEN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on FGEN Technicals page.